Short answer
MYRIAD GENETICS INC (MYGN) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Daniel M. Skovronsky, M.D., Ph.D. resigned from Myriad Genetics’ board effective immediately.
MYRIAD GENETICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Daniel M. Skovronsky, M.D., Ph.D. resigned from Myriad Genetics’ board effective immediately
- Resignation not related to disagreements, operations, policies, or company practices
- Immediate board departure creates a director vacancy and potential governance transition for investors to monitor
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MYRIAD GENETICS INC 8-K filings
Get the next MYGN 8-K as it lands
Follow MYGN for push alerts, or ask the research agent what this filing means.